![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Baxter Intnl. | LSE:BAX | London | Ordinary Share | COM STK $1 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
DOW JONES NEWSWIRES
Baxter International Inc. (BAX) said Wednesday the Food and Drug Administration classified what it had called an "urgent device correction" on its Colleague intravenous-fluid pumps as a Class I recall because of "the risk of serious injury or patient death if affected devices malfunction."
The infusion pumps have been a long-running problem for the medical-device maker.
Baxter's shares were down 2 cents at $51.32 in premarket trading.
In a January letter, Baxter notified consumers of failure codes in the pumps that may cause them to stop infusing while delivering medication and fluids to patients. The letter also warned of the possibility of the device's overheating, resulting in smoke and fire.
The FDA's recall, which is its most stringent, includes several model numbers.
-By Kerry E. Grace, Dow Jones Newswires; 201-938-5089; kerry.grace@dowjones.com
1 Year Baxter Intnl. Chart |
1 Month Baxter Intnl. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions